S Manoj Kumar Reddy 's Insider Trades & SAST Disclosures
S Manoj Kumar Reddy 's most recent trade in Concord Drugs Ltd. was a Acquisition of 171,133 Equity Shares done at an average price of Rs. 24.8 . Disclosure was reported to the exchange on Oct. 30, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
S Manoj Kumar Reddy 's has made SAST transactions in Concord Drugs Ltd. recently where a Acquisition of 342,266 shares done . Disclosure was reported to the exchange on Oct. 30, 2023.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Drugs | S Manoj Kumar Reddy & PACs | Promoter | Acquisition | 31 Oct 2023 | 342,266 | 5,540,649 (55.40%) | 3.52% | - | 27 Oct 2023 27 Oct 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S.Manoj Kumar Reddy | Promoter & Director | Acquisition | 30 Oct 2023 | 171,133 | 1,628,125 (16.28%) | 1.84% | 24.8 | 4,235,542 | 27 Oct 2023 27 Oct 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S.Manoj Kumar Reddy | Promoter & Director | Disposal | 30 Oct 2023 | 171,133 | 0 (0%) | 1.84% | 24.8 | 4,235,542 | 27 Oct 2023 27 Oct 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S Manoj Kumar Reddy & PACs | Promoter | Acquisition | 17 Oct 2023 | 342,264 | 5,198,383 (53.83%) | 3.54% | - | 12 Oct 2023 12 Oct 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S.Manoj Kumar Reddy | Promoter & Director | Disposal | 14 Oct 2023 | 171,132 | 171,133 (0%) | 1.84% | 24.8 | 4,235,517 | 12 Oct 2023 12 Oct 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S.Manoj Kumar Reddy | Promoter & Director | Acquisition | 14 Oct 2023 | 171,132 | 1,456,992 (15.09%) | 1.84% | 24.8 | 4,235,517 | 12 Oct 2023 12 Oct 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S Manoj Kumar Reddy | Promoter | Acquisition | 31 Mar 2023 | 285,860 | 1,285,860 (13.80%) | 3.07% | - | 28 Mar 2023 28 Mar 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S. Manoj Kumar Reddy | Promoter & Director | Acquisition | 30 Sep 2021 | 223,277 | 1,000,000 (11.44%) | 2.55% | 0 | 0 | 20 Sep 2021 28 Sep 2021 |
Insider Trading | Equity Shares | Gift |
| Concord Drugs | S Manoj Kumar Reddy | Promoter | Acquisition | 01 Oct 2021 | 223,277 | 1,000,000 (11.44%) | 2.56% | - | 24 Sep 2021 28 Sep 2021 |
SAST (29(2)) | - | Off Market | |
| Concord Drugs | S. Manoj Kumar Reddy | Promoter & Director | Acquisition | 22 Sep 2021 | 72,529 | 776,723 (8.88%) | 0.83% | 27.5 | 1,996,266 | 20 Sep 2021 21 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | S Manoj Kumar Reddy | Promoter | Acquisition | 22 Sep 2021 | 72,529 | 776,723 (8.88%) | 0.82% | - | 20 Sep 2021 21 Sep 2021 |
SAST (29(2)) | - | Market | |
| Concord Drugs | S. Manoj Kumar Reddy | Promoter & Director | Acquisition | 16 Sep 2021 | 39,194 | 704,194 (8.06%) | 0.45% | 26.2 | 1,026,394 | 31 Aug 2021 14 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | S Manoj Kumar Reddy | Promoter | Acquisition | 17 Sep 2021 | 39,194 | 704,194 (8.06%) | 0.45% | - | 31 Aug 2021 14 Sep 2021 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.